← Back to Search

Visual Feedback for Sensory and Motor Learning

N/A
Recruiting
Led By Hannah J Block
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between the ages of 18-45 years old
Individuals who report being free of Covid symptoms in week preceding testing
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

This trial will examine how different visual displays change a person's perception of where their hand is.

Who is the study for?
This trial is for right-handed individuals aged 18-45 who are fully vaccinated against COVID-19 or have a recent negative test. They must not have any history of severe neurological issues, learning conditions like ADHD, orthopedic problems, impaired vision, seizures, or serious arm injuries.Check my eligibility
What is being tested?
The study explores how people perceive their hand position when given different visual cues. Participants will try to point out where they think their hand is under various scenarios including altered feedback and direct vision.See study design
What are the potential side effects?
Since this study involves basic sensory and motor tasks without medical interventions, there are no significant side effects expected apart from the usual risks associated with participating in movement studies such as mild fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 45 years old.
Select...
I haven't had any Covid symptoms in the last week.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Realignment
Secondary outcome measures
Target estimation variance
Visuo-proprioceptive weighting

Trial Design

6Treatment groups
Experimental Treatment
Placebo Group
Group I: Movement feedback: Target handExperimental Treatment1 Intervention
Movement feedback about the target hand.
Group II: Movement feedback: Pointing handExperimental Treatment1 Intervention
Movement feedback about the pointing hand.
Group III: Conscious awareness: Explanatory diagramExperimental Treatment1 Intervention
Told in advance about the visuo-proprioceptive mismatch, which will be explained with a diagram. Hand remains hidden.
Group IV: Conscious awareness: Direct vision of handExperimental Treatment1 Intervention
Foamboard under mirror removed, making the mirror see-through and the hand directly visible.
Group V: Conscious awareness: No informationPlacebo Group1 Intervention
Told nothing about the visuo-proprioceptive mismatch. Hand remains hidden beneath mirror that shows visual display. (control)
Group VI: Movement feedback: No feedbackPlacebo Group1 Intervention
No movement feedback (control)

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
981,501 Total Patients Enrolled
3 Trials studying Basic Science
520 Patients Enrolled for Basic Science
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,341 Previous Clinical Trials
649,089 Total Patients Enrolled
3 Trials studying Basic Science
520 Patients Enrolled for Basic Science
Hannah J BlockPrincipal InvestigatorIndiana University, Bloomington

Media Library

Movement feedback, target hand Clinical Trial Eligibility Overview. Trial Name: NCT05374460 — N/A
Basic Science Research Study Groups: Conscious awareness: Direct vision of hand, Conscious awareness: Explanatory diagram, Conscious awareness: No information, Movement feedback: No feedback, Movement feedback: Target hand, Movement feedback: Pointing hand
Basic Science Clinical Trial 2023: Movement feedback, target hand Highlights & Side Effects. Trial Name: NCT05374460 — N/A
Movement feedback, target hand 2023 Treatment Timeline for Medical Study. Trial Name: NCT05374460 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment in this experiment available at present?

"Correct. According to records available on clinicaltrials.gov, this medical trial began recruitment efforts in April of 2022 and is still actively engaging with participants as of October 13th 2022. The aim is to enrol 300 patients at one location."

Answered by AI

What are the prerequisites for participation in this trial?

"This medical trial is seeking 300 right-handed volunteers aged 18 to 45 who possess basic science knowledge. Moreover, participants must have been fully vaccinated against Covid (2+ weeks after their final dose) or achieved a negative Covid test within the last 4 days and reported no symptoms during the week preceding testing."

Answered by AI

Does this trial permit those over fifty years of age to participate?

"Consistent with the prerequisites of this research, participants cannot be under 18 or beyond 45 years old."

Answered by AI

What is the current enrollment number for this trial?

"Affirmative, the information posted on clinicaltrials.gov indicates that this medical study is presently enrolling patients. The trial was initially advertised on April 29th 2022 and recently amended on October 13th of the same year. 300 participants are required for recruitment from 1 site only."

Answered by AI

Who else is applying?

What state do they live in?
Indiana
How old are they?
18 - 65
What site did they apply to?
Hannah Block
What portion of applicants met pre-screening criteria?
Met criteria
~100 spots leftby Apr 2025